Home » Topics » Conferences

Conferences
RSS

CRF1 receptor antagonist may be beneficial in stress-induced psychosomatic disorders

June 24, 1999

Potential new use for donepezil: Rx of dyskinesias and other symptoms in IPD

June 24, 1999

Early indications of antidiabetic potential for adenosine A1 agonist from Glaxo Wellcome

June 24, 1999

Antidiabetic activity and mechanism of action of R-102380, a novel TZD from Sankyo

June 24, 1999

Calyx scientists identify CLX-0301, a novel antidiabetic and candidate for clinical testing

June 24, 1999

CLX-0901: a novel compound for the treatment of type II diabetes

June 24, 1999

Ovine colostrum-derived polypeptide may represent novel treatment strategy in AD

June 23, 1999

UCB's levetiracetam superior to placebo in refractory partial seizures

June 23, 1999

New study provides evidence supporting efficacy of cladribine in MS

June 23, 1999

New antidiabetic agents in the pipeline at Calyx

June 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...